Search research articles
Contact Us
Filters
Showing results (221-230 of 253) with videos related to
Page
of 26
Sort By:
Leukemia & Lymphoma
|
April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure
Emily Anderson, Yun Choi, Rachel J Buchsbaum, et al.
Blood
|
August 16, 2005
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project
Charles L Bennett, Denis Cournoyer, Kenneth R Carson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826
Sharon M Castellino, Hongli Li, Alex F Herrera, et al.
Blood Advances
|
August 27, 2021
Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma
Victor M Orellana-Noia, Krista Isaac, Mary-Kate Malecek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2025
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826
Sarah C Rutherford, Hongli Li, Alex F Herrera, et al.
Blood Advances
|
January 4, 2018
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL
Monika Pilichowska, Stefania Pittaluga, Judith A Ferry, et al.
Cancer
|
September 14, 2017
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis
Tara O Henderson, Susan K Parsons, Kristen E Wroblewski, et al.
Blood
|
March 7, 2009
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R Carson, Andrew M Evens, Elizabeth A Richey, et al.
Cancer
|
July 28, 2017
C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy
Narendranath Epperla, Kami J Maddocks, Mohammed Salhab, et al.
American Journal of Hematology
|
November 24, 2016
Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies
Luciano J Costa, Kami Maddocks, Narendranath Epperla, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 253) with videos related to
Sort By:
Page
of 26
Leukemia & Lymphoma
|
April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure
Emily Anderson, Yun Choi, Rachel J Buchsbaum, et al.
Blood
|
August 16, 2005
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project
Charles L Bennett, Denis Cournoyer, Kenneth R Carson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826
Sharon M Castellino, Hongli Li, Alex F Herrera, et al.
Blood Advances
|
August 27, 2021
Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma
Victor M Orellana-Noia, Krista Isaac, Mary-Kate Malecek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2025
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826
Sarah C Rutherford, Hongli Li, Alex F Herrera, et al.
Blood Advances
|
January 4, 2018
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL
Monika Pilichowska, Stefania Pittaluga, Judith A Ferry, et al.
Cancer
|
September 14, 2017
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis
Tara O Henderson, Susan K Parsons, Kristen E Wroblewski, et al.
Blood
|
March 7, 2009
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R Carson, Andrew M Evens, Elizabeth A Richey, et al.
Cancer
|
July 28, 2017
C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy
Narendranath Epperla, Kami J Maddocks, Mohammed Salhab, et al.
American Journal of Hematology
|
November 24, 2016
Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies
Luciano J Costa, Kami Maddocks, Narendranath Epperla, et al.
Page
of 26